Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141272 |
| CAS No | NA |
| Mol.F. | C26H28N6O4 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141273 |
| CAS No | NA |
| Mol.F. | C28H29N5O4 |
| Mol.Wt. | 499.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141274 |
| CAS No | 117782-96-4 |
| Mol.F. | C8H6N2O |
| Mol.Wt. | 146.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141270 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141275 |
| CAS No | 6130-93-4 |
| Mol.F. | C9H18N2O |
| Mol.Wt. | 170.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141276 |
| CAS No | 37137-26-1 |
| Mol.F. | C5H7N3O3 |
| Mol.Wt. | 157.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141277 |
| CAS No | NA |
| Mol.F. | C6H10N2O3 |
| Mol.Wt. | 158.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141278 |
| CAS No | NA |
| Mol.F. | C6H8N2O2 |
| Mol.Wt. | 140.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141279 |
| CAS No | 2089333-12-8 |
| Mol.F. | C9H11N5O3 |
| Mol.Wt. | 237.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141280 |
| CAS No | NA |
| Mol.F. | C14H21N5O4 |
| Mol.Wt. | 323.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141281 |
| CAS No | NA |
| Mol.F. | C33H44N8O5 |
| Mol.Wt. | 632.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141282 |
| CAS No | NA |
| Mol.F. | C27H33BrN8O4 |
| Mol.Wt. | 613.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141283 |
| CAS No | NA |
| Mol.F. | C25H26N6O3 |
| Mol.Wt. | 458.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141284 |
| CAS No | NA |
| Mol.F. | C14H30N2O6 |
| Mol.Wt. | 322.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141285 |
| CAS No | NA |
| Mol.F. | C10H22N2O6 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141286 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2(Na) |
| Mol.Wt. | 449.4 : 2(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |